Replies to post #193726 on Biotech Values

[DewDiligence]

(REGN/SNY/AMGN/ESPR)—Statin intolerance:

http://www.wsj.com/articles/patients-seeking-alternatives-to-statins-may-undergo-rigorous-vetting-1438029636

A [Cleveland Clinic] study…involving about 1,600 patients with initial complaints of statin intolerance found that just over 70% could actually take the medicines, while about 30% were truly statin-intolerant.